Dinalo, Mylyn .

HRN: 21-10-20  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/30/2023
CEFUROXIME 500MG (TAB)
05/30/2023
06/06/2023
PO
1 Tab
BID
SP NSVD W Repair; UTI
Waiting Final Action 

Indication:  Empiric    Type of Infection:  Urinary TractReproductive Tract    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: